The new issue of AGA Perspectives examines the use of anti-TNF therapy, the promising outlook of stool DNA testing and revisits the gut microbiome of AGA members.
AGA is tracking outcomes of fecal microbiota transplantation through an observational registry.
AGA microbiome expert Dr. Geoffrey A. Preidis weighs in on this new study and why the findings are clinically relevant.
Dr. Kaplan and Dr. Kashyap, members of AGA’s Center for Gut Microbiome Research and Education Scientific Advisory Board, weigh in on probiotics debate.
AGA Institute Council’s newest section, Microbiome & Microbial Diseases in the Gastrointestinal Tract, is set to host it’s first year of programming at DDW.
Dr. Rob Knight and colleagues provide insight into the different techniques for assaying the microbiome via DNA sequencing.